Tenofovir disoproxil fumarate/emtricitabine/rilpivirine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Tenofovir disoproxil fumarate/emtricitabine/rilpivirine, covering 2017-07-26 to 2017-07-26. Get the full timeline:
Most recent: Clinical Trial Update: A Pilot Study to Assess the Feasibility of Switching, Individuals Receiving Atripla With Continuing Central Nervous System (CNS) Toxicity, to a Fixed Dose Combination of Tenofovir/Emtricitabine/Rilpivirine [Phase 3]